25 XP   0   0   10

STRATA Skin Sciences Inc
Buy, Hold or Sell?

Let's analyse STRATA Skin Sciences Inc together

PenkeI guess you are interested in STRATA Skin Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of STRATA Skin Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about STRATA Skin Sciences Inc

I send you an email if I find something interesting about STRATA Skin Sciences Inc.

Quick analysis of STRATA Skin Sciences Inc (30 sec.)










What can you expect buying and holding a share of STRATA Skin Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.46
Expected worth in 1 year
$0.30
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.16
Return On Investment
-36.0%

For what price can you sell your share?

Current Price per Share
$0.44
Expected price per share
$0.262 - $0.6
How sure are you?
50%

1. Valuation of STRATA Skin Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.44

Intrinsic Value Per Share

$-3.09 - $1.12

Total Value Per Share

$-2.62 - $1.58

2. Growth of STRATA Skin Sciences Inc (5 min.)




Is STRATA Skin Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$16.1m$23.3m-$4.7m-25.7%

How much money is STRATA Skin Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$2m$155.5k8.0%
Net Profit Margin-24.0%-22.6%--

How much money comes from the company's main activities?

3. Financial Health of STRATA Skin Sciences Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#224 / 340

Most Revenue
#197 / 340

Most Profit
#175 / 340

Most Efficient
#185 / 340

What can you expect buying and holding a share of STRATA Skin Sciences Inc? (5 min.)

Welcome investor! STRATA Skin Sciences Inc's management wants to use your money to grow the business. In return you get a share of STRATA Skin Sciences Inc.

What can you expect buying and holding a share of STRATA Skin Sciences Inc?

First you should know what it really means to hold a share of STRATA Skin Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of STRATA Skin Sciences Inc is $0.4449. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of STRATA Skin Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in STRATA Skin Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.46. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of STRATA Skin Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.03-6.8%-0.07-15.8%-0.04-10.0%-0.03-6.8%-0.07-16.0%
Usd Book Value Change Per Share-0.02-4.6%-0.04-9.0%-0.03-7.0%-0.02-5.5%0.000.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-4.6%-0.04-9.0%-0.03-7.0%-0.02-5.5%0.000.9%
Usd Price Per Share0.60-0.85-1.19-1.52-1.40-
Price to Earnings Ratio-4.95--3.33--8.10--10.78--8.38-
Price-to-Total Gains Ratio-29.13-208.90--44.56--57.18-11.71-
Price to Book Ratio1.29-1.61-1.77-2.06-2.54-
Price-to-Total Gains Ratio-29.13-208.90--44.56--57.18-11.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4449
Number of shares2247
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.04-0.02
Usd Total Gains Per Share-0.04-0.02
Gains per Quarter (2247 shares)-89.87-55.08
Gains per Year (2247 shares)-359.47-220.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-359-3690-220-230
20-719-7280-441-450
30-1078-10870-661-670
40-1438-14460-881-890
50-1797-18050-1102-1110
60-2157-21640-1322-1330
70-2516-25230-1542-1550
80-2876-28820-1763-1770
90-3235-32410-1983-1990
100-3595-36000-2203-2210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%4.036.00.010.0%4.072.00.05.3%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%12.027.01.030.0%22.052.02.028.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.076.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%12.027.01.030.0%22.052.02.028.9%

Fundamentals of STRATA Skin Sciences Inc

About STRATA Skin Sciences Inc

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also provides TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Fundamental data was last updated by Penke on 2024-03-22 04:35:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of STRATA Skin Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit STRATA Skin Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -11.9% means that $-0.12 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of STRATA Skin Sciences Inc:

  • The MRQ is -11.9%. The company is making a huge loss. -2
  • The TTM is -24.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-11.9%TTM-24.0%+12.1%
TTM-24.0%YOY-22.6%-1.4%
TTM-24.0%5Y-17.1%-6.9%
5Y-17.1%10Y-626.5%+609.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.9%-11.0%-0.9%
TTM-24.0%-20.2%-3.8%
YOY-22.6%-14.0%-8.6%
5Y-17.1%-19.5%+2.4%
10Y-626.5%-23.8%-602.7%
1.1.2. Return on Assets

Shows how efficient STRATA Skin Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
  • -2.2% Return on Assets means that STRATA Skin Sciences Inc generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of STRATA Skin Sciences Inc:

  • The MRQ is -2.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.2%TTM-3.8%+1.5%
TTM-3.8%YOY-4.0%+0.3%
TTM-3.8%5Y-2.5%-1.2%
5Y-2.5%10Y-8.0%+5.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.2%-3.1%+0.9%
TTM-3.8%-4.2%+0.4%
YOY-4.0%-4.0%0.0%
5Y-2.5%-3.8%+1.3%
10Y-8.0%-4.1%-3.9%
1.1.3. Return on Equity

Shows how efficient STRATA Skin Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
  • -6.5% Return on Equity means STRATA Skin Sciences Inc generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of STRATA Skin Sciences Inc:

  • The MRQ is -6.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-10.8%+4.3%
TTM-10.8%YOY-8.9%-1.9%
TTM-10.8%5Y-5.6%-5.2%
5Y-5.6%10Y-17.5%+11.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.5%-3.5%-3.0%
TTM-10.8%-4.4%-6.4%
YOY-8.9%-4.7%-4.2%
5Y-5.6%-5.7%+0.1%
10Y-17.5%-6.2%-11.3%

1.2. Operating Efficiency of STRATA Skin Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient STRATA Skin Sciences Inc is operating .

  • Measures how much profit STRATA Skin Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
  • An Operating Margin of -24.3% means the company generated $-0.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of STRATA Skin Sciences Inc:

  • The MRQ is -24.3%. The company is operating very inefficient. -2
  • The TTM is -20.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-24.3%TTM-20.2%-4.1%
TTM-20.2%YOY-20.0%-0.2%
TTM-20.2%5Y-16.1%-4.1%
5Y-16.1%10Y-519.3%+503.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.3%-24.5%+0.2%
TTM-20.2%-14.9%-5.3%
YOY-20.0%-11.5%-8.5%
5Y-16.1%-17.1%+1.0%
10Y-519.3%-20.6%-498.7%
1.2.2. Operating Ratio

Measures how efficient STRATA Skin Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.07 means that the operating costs are $1.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of STRATA Skin Sciences Inc:

  • The MRQ is 1.069. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.159. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.069TTM1.159-0.090
TTM1.159YOY1.349-0.190
TTM1.1595Y1.193-0.034
5Y1.19310Y5.796-4.603
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0691.454-0.385
TTM1.1591.452-0.293
YOY1.3491.434-0.085
5Y1.1931.432-0.239
10Y5.7961.366+4.430

1.3. Liquidity of STRATA Skin Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if STRATA Skin Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.64 means the company has $1.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of STRATA Skin Sciences Inc:

  • The MRQ is 1.640. The company is able to pay all its short-term debts. +1
  • The TTM is 1.390. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.640TTM1.390+0.250
TTM1.390YOY1.376+0.014
TTM1.3905Y1.593-0.203
5Y1.59310Y1.991-0.398
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6402.789-1.149
TTM1.3902.793-1.403
YOY1.3763.586-2.210
5Y1.5933.492-1.899
10Y1.9913.450-1.459
1.3.2. Quick Ratio

Measures if STRATA Skin Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.99 means the company can pay off $0.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of STRATA Skin Sciences Inc:

  • The MRQ is 0.992. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.800. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.992TTM0.800+0.192
TTM0.800YOY0.977-0.177
TTM0.8005Y1.085-0.285
5Y1.08510Y1.345-0.260
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9921.587-0.595
TTM0.8001.633-0.833
YOY0.9772.155-1.178
5Y1.0852.300-1.215
10Y1.3452.255-0.910

1.4. Solvency of STRATA Skin Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of STRATA Skin Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare STRATA Skin Sciences Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.66 means that STRATA Skin Sciences Inc assets are financed with 65.7% credit (debt) and the remaining percentage (100% - 65.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of STRATA Skin Sciences Inc:

  • The MRQ is 0.657. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.635. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.657TTM0.635+0.022
TTM0.635YOY0.549+0.086
TTM0.6355Y0.481+0.154
5Y0.48110Y0.502-0.021
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6570.400+0.257
TTM0.6350.386+0.249
YOY0.5490.330+0.219
5Y0.4810.440+0.041
10Y0.5020.460+0.042
1.4.2. Debt to Equity Ratio

Measures if STRATA Skin Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 191.4% means that company has $1.91 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of STRATA Skin Sciences Inc:

  • The MRQ is 1.914. The company is just able to pay all its debts with equity.
  • The TTM is 1.779. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.914TTM1.779+0.135
TTM1.779YOY1.248+0.531
TTM1.7795Y1.021+0.758
5Y1.02110Y1.171-0.150
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9140.570+1.344
TTM1.7790.569+1.210
YOY1.2480.479+0.769
5Y1.0210.626+0.395
10Y1.1710.692+0.479

2. Market Valuation of STRATA Skin Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings STRATA Skin Sciences Inc generates.

  • Above 15 is considered overpriced but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
  • A PE ratio of -4.95 means the investor is paying $-4.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of STRATA Skin Sciences Inc:

  • The EOD is -3.702. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.951. Based on the earnings, the company is expensive. -2
  • The TTM is -3.327. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.702MRQ-4.951+1.249
MRQ-4.951TTM-3.327-1.624
TTM-3.327YOY-8.097+4.770
TTM-3.3275Y-10.775+7.448
5Y-10.77510Y-8.376-2.399
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.702-1.038-2.664
MRQ-4.951-1.216-3.735
TTM-3.327-1.757-1.570
YOY-8.097-2.588-5.509
5Y-10.775-1.553-9.222
10Y-8.376-1.463-6.913
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of STRATA Skin Sciences Inc:

  • The EOD is -2.135. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.855. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.494. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.135MRQ-2.855+0.720
MRQ-2.855TTM-5.494+2.639
TTM-5.494YOY-14.017+8.524
TTM-5.4945Y181.241-186.734
5Y181.24110Y90.243+90.997
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.135-1.228-0.907
MRQ-2.855-1.746-1.109
TTM-5.494-2.961-2.533
YOY-14.017-6.157-7.860
5Y181.241-4.928+186.169
10Y90.243-5.626+95.869
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of STRATA Skin Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.29 means the investor is paying $1.29 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of STRATA Skin Sciences Inc:

  • The EOD is 0.963. Based on the equity, the company is cheap. +2
  • The MRQ is 1.288. Based on the equity, the company is underpriced. +1
  • The TTM is 1.611. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.963MRQ1.288-0.325
MRQ1.288TTM1.611-0.324
TTM1.611YOY1.774-0.162
TTM1.6115Y2.065-0.453
5Y2.06510Y2.542-0.477
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.9632.038-1.075
MRQ1.2882.321-1.033
TTM1.6112.444-0.833
YOY1.7743.047-1.273
5Y2.0653.918-1.853
10Y2.5424.245-1.703
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of STRATA Skin Sciences Inc.

3.1. Institutions holding STRATA Skin Sciences Inc

Institutions are holding 66.993% of the shares of STRATA Skin Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC17.85010.10296256264299131991.6193
2023-12-3122NW, LP15.32131.9242536995400
2023-12-31Renaissance Technologies Corp3.04560.00091067453-11700-1.0842
2023-12-31Vanguard Group Inc2.4486085820200
2023-12-31Cannell Capital LLC0.78690.0329275806-75805-21.5593
2023-12-31Goldman Sachs Group Inc0.3768013205866033100.0121
2023-12-31Geode Capital Management, LLC0.3156011062100
2023-12-31Creative Planning Inc0.28580.00011001601500.15
2023-12-31Perritt Capital Management Inc.0.28530.030810000000
2023-12-31BlackRock Inc0.278097436-1739-1.7535
2023-12-31We Are One Seven, LLC0.20380.00237142000
2023-12-31Chicago Partners Investment Group LLC0.18320.00156422339706161.9529
2023-09-30PNC Financial Services Group Inc0.090503173300
2023-12-31Northern Trust Corp0.077502717000
2023-12-31State Street Corporation0.032701145000
2023-12-31Tower Research Capital LLC0.03080.0001107985657110.037
2023-12-31Carmichael Hill & Associates Inc0.00860.0007300000
2023-12-31JPMorgan Chase & Co0.001806346092436
2023-12-31Morgan Stanley - Brokerage Accounts0.0015051000
2023-12-31Royal Bank of Canada0.00090320272566.6667
Total 41.62532.096414589212+3014502+20.7%

3.2. Funds holding STRATA Skin Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Total Stock Mkt Idx Inv1.6926059324800
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr0.67180.000123545400
2023-12-31Perritt Ultra MicroCap0.28530.496710000000
2024-01-31Fidelity Extended Market Index0.25070.00018786700
2024-02-29iShares Micro-Cap ETF0.12030.00234215500
2024-01-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.060402117100
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.0604021171-572077-96.4313
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05630.00021971600
2023-12-31Northern Trust Extended Eq Market Idx0.05630.00021971600
2024-01-31Fidelity Nasdaq Composite Index0.04980.00011744700
2024-01-31Fidelity Series Total Market Index0.038101334010579383.1583
2024-01-31Vanguard Balanced Index Inv0.02380832900
2023-09-30BlackRock Extended Mkt Composite0.01760617900
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.01610.0001565200
2023-12-31BlackRock Extended Equity Market K0.015405391-11-0.2036
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0130.0001453990.1987
2024-01-311290 VT Micro Cap K0.01110.0015389500
2024-01-31Spartan Extended Market Index Pool E0.00530.0001185500
2023-12-31Northern Trust Wilshire 50000.00480168300
2023-12-31NT US Market Cap Idx Fd - L0.00480168300
Total 3.45390.50151210491-561500-46.4%

3.3. Insider Transactions

Insiders are holding 4.266% of the shares of STRATA Skin Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-01Shmuel GovBUY200000.45
2023-11-16Samuel RubinsteinSELL10000.32
2023-08-10Christopher LesovitzBUY151510.67
2023-08-10Robert Joseph MocciaBUY420000.67

4. Summary

4.1. Key Performance Indicators

The key performance indicators of STRATA Skin Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.020-0.040+96%-0.031+53%-0.025+20%0.004-585%
Book Value Per Share--0.4620.530-13%0.666-31%0.714-35%0.598-23%
Current Ratio--1.6401.390+18%1.376+19%1.593+3%1.991-18%
Debt To Asset Ratio--0.6570.635+3%0.549+20%0.481+37%0.502+31%
Debt To Equity Ratio--1.9141.779+8%1.248+53%1.021+87%1.171+63%
Dividend Per Share----0%-0%-0%-0%
Eps---0.030-0.070+134%-0.044+48%-0.030+1%-0.071+137%
Free Cash Flow Per Share---0.052-0.048-8%-0.026-51%-0.017-68%-0.027-48%
Free Cash Flow To Equity Per Share---0.0550.047-217%-0.016-72%0.030-283%0.056-198%
Gross Profit Margin--3.8858.184-53%3.650+6%4.678-17%3.297+18%
Intrinsic Value_10Y_max--1.120--------
Intrinsic Value_10Y_min---3.087--------
Intrinsic Value_1Y_max---0.077--------
Intrinsic Value_1Y_min---0.151--------
Intrinsic Value_3Y_max---0.087--------
Intrinsic Value_3Y_min---0.593--------
Intrinsic Value_5Y_max--0.077--------
Intrinsic Value_5Y_min---1.186--------
Market Cap15593211.120-34%20854036.00029736278.140-30%41769407.400-50%53267174.256-61%49234981.052-58%
Net Profit Margin---0.119-0.240+102%-0.226+90%-0.171+44%-6.265+5167%
Operating Margin---0.243-0.202-17%-0.200-18%-0.161-34%-5.193+2035%
Operating Ratio--1.0691.159-8%1.349-21%1.193-10%5.796-82%
Pb Ratio0.963-34%1.2881.611-20%1.774-27%2.065-38%2.542-49%
Pe Ratio-3.702+25%-4.951-3.327-33%-8.097+64%-10.775+118%-8.376+69%
Price Per Share0.445-34%0.5950.848-30%1.192-50%1.518-61%1.404-58%
Price To Free Cash Flow Ratio-2.135+25%-2.855-5.494+92%-14.017+391%181.241-102%90.243-103%
Price To Total Gains Ratio-21.778+25%-29.126208.895-114%-44.556+53%-57.184+96%11.712-349%
Quick Ratio--0.9920.800+24%0.977+2%1.085-9%1.345-26%
Return On Assets---0.022-0.038+69%-0.040+81%-0.025+13%-0.080+258%
Return On Equity---0.065-0.108+66%-0.089+37%-0.056-13%-0.175+169%
Total Gains Per Share---0.020-0.040+96%-0.031+53%-0.025+20%0.004-585%
Usd Book Value--16193000.00018563500.000-13%23333500.000-31%25059850.000-35%20985985.550-23%
Usd Book Value Change Per Share---0.020-0.040+96%-0.031+53%-0.025+20%0.004-585%
Usd Book Value Per Share--0.4620.530-13%0.666-31%0.714-35%0.598-23%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.030-0.070+134%-0.044+48%-0.030+1%-0.071+137%
Usd Free Cash Flow---1826000.000-1677750.000-8%-900250.000-51%-585500.000-68%-951879.825-48%
Usd Free Cash Flow Per Share---0.052-0.048-8%-0.026-51%-0.017-68%-0.027-48%
Usd Free Cash Flow To Equity Per Share---0.0550.047-217%-0.016-72%0.030-283%0.056-198%
Usd Market Cap15593211.120-34%20854036.00029736278.140-30%41769407.400-50%53267174.256-61%49234981.052-58%
Usd Price Per Share0.445-34%0.5950.848-30%1.192-50%1.518-61%1.404-58%
Usd Profit---1053000.000-1932750.000+84%-2088250.000+98%-1258149.950+19%-2562993.725+143%
Usd Revenue--8852000.0008817750.000+0%10028500.000-12%7971350.000+11%6640074.850+33%
Usd Total Gains Per Share---0.020-0.040+96%-0.031+53%-0.025+20%0.004-585%
 EOD+3 -5MRQTTM+17 -17YOY+17 -175Y+16 -1810Y+13 -21

4.2. Fundamental Score

Let's check the fundamental score of STRATA Skin Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.702
Price to Book Ratio (EOD)Between0-10.963
Net Profit Margin (MRQ)Greater than0-0.119
Operating Margin (MRQ)Greater than0-0.243
Quick Ratio (MRQ)Greater than10.992
Current Ratio (MRQ)Greater than11.640
Debt to Asset Ratio (MRQ)Less than10.657
Debt to Equity Ratio (MRQ)Less than11.914
Return on Equity (MRQ)Greater than0.15-0.065
Return on Assets (MRQ)Greater than0.05-0.022
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of STRATA Skin Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.507
Ma 20Greater thanMa 500.502
Ma 50Greater thanMa 1000.515
Ma 100Greater thanMa 2000.513
OpenGreater thanClose0.470
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Income Tax Expense  209-14663472535-237298-1,836-1,538



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets47,193
Total Liabilities31,000
Total Stockholder Equity16,193
 As reported
Total Liabilities 31,000
Total Stockholder Equity+ 16,193
Total Assets = 47,193

Assets

Total Assets47,193
Total Current Assets19,722
Long-term Assets27,471
Total Current Assets
Cash And Cash Equivalents 7,131
Net Receivables 4,802
Inventory 6,125
Other Current Assets 330
Total Current Assets  (as reported)19,722
Total Current Assets  (calculated)18,388
+/- 1,334
Long-term Assets
Property Plant Equipment 8,974
Goodwill 8,803
Intangible Assets 9,623
Long-term Assets Other 71
Long-term Assets  (as reported)27,471
Long-term Assets  (calculated)27,471
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,025
Long-term Liabilities18,975
Total Stockholder Equity16,193
Total Current Liabilities
Short-term Debt 404
Accounts payable 3,157
Other Current Liabilities 6,079
Total Current Liabilities  (as reported)12,025
Total Current Liabilities  (calculated)9,640
+/- 2,385
Long-term Liabilities
Long term Debt 15,016
Capital Lease Obligations 686
Long-term Liabilities Other 3,371
Long-term Liabilities  (as reported)18,975
Long-term Liabilities  (calculated)19,073
+/- 98
Total Stockholder Equity
Common Stock35
Retained Earnings -234,264
Other Stockholders Equity 250,422
Total Stockholder Equity (as reported)16,193
Total Stockholder Equity (calculated)16,193
+/-0
Other
Capital Stock35
Cash and Short Term Investments 7,131
Common Stock Shares Outstanding 34,912
Current Deferred Revenue2,385
Liabilities and Stockholders Equity 47,193
Net Debt 8,571
Net Invested Capital 31,209
Net Working Capital 7,697
Property Plant and Equipment Gross 32,691
Short Long Term Debt Total 15,702



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-30
> Total Assets 
0
7,096
0
4,997
3,643
19,166
16,705
13,959
11,544
22,476
19,728
16,628
24,772
22,108
18,342
13,723
20,573
16,620
12,655
8,963
26,128
32,127
32,515
28,208
38,858
33,589
28,814
24,169
20,296
31,393
26,125
21,901
20,140
17,270
31,835
26,600
13,149
14,132
17,354
12,491
24,313
20,070
16,222
54,412
52,154
51,372
47,509
44,406
42,950
43,193
43,207
42,902
39,864
38,631
38,631
45,652
46,190
47,507
47,739
47,967
47,507
47,343
46,047
46,210
47,064
46,778
45,854
44,899
46,758
46,593
55,087
53,587
53,235
52,272
49,123
55,204
47,193
47,19355,20449,12352,27253,23553,58755,08746,59346,75844,89945,85446,77847,06446,21046,04747,34347,50747,96747,73947,50746,19045,65238,63138,63139,86442,90243,20743,19342,95044,40647,50951,37252,15454,41216,22220,07024,31312,49117,35414,13213,14926,60031,83517,27020,14021,90126,12531,39320,29624,16928,81433,58938,85828,20832,51532,12726,1288,96312,65516,62020,57313,72318,34222,10824,77216,62819,72822,47611,54413,95916,70519,1663,6434,99707,0960
   > Total Current Assets 
0
6,813
0
4,726
3,345
18,873
16,228
13,382
10,851
21,771
18,907
15,797
23,965
21,328
17,396
12,809
19,720
15,836
11,950
8,051
25,190
30,338
30,521
25,657
36,149
31,044
26,409
21,877
17,859
29,058
23,530
18,417
14,652
9,683
23,130
16,385
3,608
10,351
14,270
8,531
20,532
17,203
13,877
13,403
11,962
11,979
10,896
9,555
9,388
10,752
10,525
11,358
10,053
10,752
10,752
20,260
21,774
23,210
23,515
23,654
23,210
23,555
22,797
23,889
24,936
24,831
24,103
23,462
20,046
19,970
19,046
18,628
18,753
17,504
14,512
21,245
19,722
19,72221,24514,51217,50418,75318,62819,04619,97020,04623,46224,10324,83124,93623,88922,79723,55523,21023,65423,51523,21021,77420,26010,75210,75210,05311,35810,52510,7529,3889,55510,89611,97911,96213,40313,87717,20320,5328,53114,27010,3513,60816,38523,1309,68314,65218,41723,53029,05817,85921,87726,40931,04436,14925,65730,52130,33825,1908,05111,95015,83619,72012,80917,39621,32823,96515,79718,90721,77110,85113,38216,22818,8733,3454,72606,8130
       Cash And Cash Equivalents 
0
109
0
176
1,346
18,505
7,994
6,537
9,599
20,940
18,157
15,076
23,272
19,197
15,900
11,763
18,776
15,070
11,254
7,747
24,779
29,673
30,043
25,315
35,756
30,521
26,041
20,943
16,999
27,997
22,301
17,211
13,276
7,862
21,647
15,152
2,620
3,783
8,123
4,202
14,466
11,434
8,233
5,553
3,169
3,303
3,120
2,841
2,957
3,928
3,763
3,938
3,127
4,069
4,069
14,445
15,888
16,487
16,389
15,941
16,487
8,129
8,150
11,231
11,063
10,604
10,043
9,576
13,047
12,586
10,923
10,036
7,454
5,434
2,825
9,034
7,131
7,1319,0342,8255,4347,45410,03610,92312,58613,0479,57610,04310,60411,06311,2318,1508,12916,48715,94116,38916,48715,88814,4454,0694,0693,1273,9383,7633,9282,9572,8413,1203,3033,1695,5538,23311,43414,4664,2028,1233,7832,62015,15221,6477,86213,27617,21122,30127,99716,99920,94326,04130,52135,75625,31530,04329,67324,7797,74711,25415,07018,77611,76315,90019,19723,27215,07618,15720,9409,5996,5377,99418,5051,34617601090
       Short-term Investments 
0
6,595
0
3,618
0
0
7,842
6,479
998
0
12,000
12,000
393
1,720
1,282
894
795
391
392
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000015100100100000000000000000000000003923917958941,2821,72039312,00012,00009986,4797,842003,61806,5950
       Net Receivables 
0
7
0
0
0
0
0
0
0
488
494
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
68
101
180
169
208
51
57
34
49
85
220
6
3,663
4,182
4,068
3,247
2,708
2,936
3,390
3,288
3,560
3,184
3,141
3,141
2,574
2,728
3,393
3,575
3,476
3,393
4,386
3,208
1,361
2,510
2,944
2,853
2,854
3,151
3,433
2,972
2,989
3,655
4,471
3,940
4,401
4,802
4,8024,4013,9404,4713,6552,9892,9723,4333,1512,8542,8532,9442,5101,3613,2084,3863,3933,4763,5753,3932,7282,5743,1413,1413,1843,5603,2883,3902,9362,7083,2474,0684,1823,663622085493457512081691801016812000000000000000000500494488000000070
       Other Current Assets 
0
33
0
909
1,993
157
157
157
157
344
256
222
300
412
213
152
148
376
304
304
411
665
478
342
393
524
368
934
860
1,062
816
664
619
966
876
747
665
880
465
332
617
274
350
678
596
465
377
252
266
617
804
373
209
533
533
828
670
536
430
630
536
513
487
430
464
331
413
526
623
462
393
696
621
691
691
528
330
3305286916916216963934626235264133314644304875135366304305366708285335332093738046172662523774655966783502746173324658806657478769666196648161,0628609343685243933424786654113043043761481522134123002222563441571571571571,9939090330
   > Long-term Assets 
0
283
0
271
298
293
476
577
693
705
822
831
807
780
946
914
853
784
705
912
938
1,789
1,994
2,551
2,710
2,545
2,405
2,292
2,437
2,335
2,595
3,484
5,488
7,587
8,705
10,215
9,542
3,781
3,084
3,960
3,781
2,867
2,345
41,009
40,192
39,393
36,613
34,851
33,562
32,441
32,682
31,544
29,811
27,879
27,879
25,392
24,416
24,297
24,224
24,313
24,297
23,788
23,250
22,321
22,128
21,947
21,751
21,437
26,712
26,623
36,041
34,959
34,482
34,768
34,611
33,959
27,471
27,47133,95934,61134,76834,48234,95936,04126,62326,71221,43721,75121,94722,12822,32123,25023,78824,29724,31324,22424,29724,41625,39227,87927,87929,81131,54432,68232,44133,56234,85136,61339,39340,19241,0092,3452,8673,7813,9603,0843,7819,54210,2158,7057,5875,4883,4842,5952,3352,4372,2922,4052,5452,7102,5511,9941,78993891270578485391494678080783182270569357747629329827102830
       Property Plant Equipment 
0
89
0
155
180
175
359
451
552
564
665
662
639
616
788
762
706
643
566
578
664
1,572
1,804
1,960
2,235
2,074
1,937
1,827
1,726
1,627
2,412
3,215
5,243
7,350
8,496
10,012
9,418
3,691
2,995
3,873
2,713
1,961
1,620
14,769
14,461
13,851
12,818
11,635
10,848
10,180
9,975
9,396
8,658
7,703
7,703
6,271
5,698
5,301
4,962
6,274
5,301
6,683
6,614
6,154
6,330
6,517
6,690
6,745
7,130
7,521
7,470
7,142
7,402
8,473
9,052
9,126
8,974
8,9749,1269,0528,4737,4027,1427,4707,5217,1306,7456,6906,5176,3306,1546,6146,6835,3016,2744,9625,3015,6986,2717,7037,7038,6589,3969,97510,18010,84811,63512,81813,85114,46114,7691,6201,9612,7133,8732,9953,6919,41810,0128,4967,3505,2433,2152,4121,6271,7261,8271,9372,0742,2351,9601,8041,5726645785666437067627886166396626655645524513591751801550890
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,028
8,928
8,928
8,928
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,803
8,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,9288,9288,9288,0280000000000000000000000000000000000000000000
       Intangible Assets 
0
163
0
87
84
84
83
85
101
101
117
129
123
118
112
106
101
95
95
89
86
83
80
77
74
71
68
65
62
59
56
53
50
47
46
44
43
42
41
39
38
37
35
17,034
15,680
15,227
14,773
14,319
13,865
13,412
13,858
13,298
12,302
11,325
11,325
10,270
9,867
9,765
9,312
8,860
9,765
7,955
7,503
7,050
6,697
6,345
5,993
5,640
10,546
10,083
19,568
18,829
18,110
17,394
16,674
15,959
9,623
9,62315,95916,67417,39418,11018,82919,56810,08310,5465,6405,9936,3456,6977,0507,5037,9559,7658,8609,3129,7659,86710,27011,32511,32512,30213,29813,85813,41213,86514,31914,77315,22715,68017,0343537383941424344464750535659626568717477808386899595101106112118123129117101101858384848701630
       Other Assets 
0
194
0
117
118
118
117
125
141
141
157
169
168
164
158
152
147
141
138
334
274
217
190
590
474
471
468
465
711
707
182
268
244
237
210
203
123
90
89
87
1,068
906
725
26,240
25,731
25,542
23,795
23,216
22,714
22,261
22,707
22,148
21,153
48
48
48
48
428
392
376
363
347
330
314
298
1,270
265
249
13,903
216
200
185
167
0
82
71
0
07182016718520021613,9032492651,2702983143303473633763924284848484821,15322,14822,70722,26122,71423,21623,79525,54225,73126,2407259061,06887899012320321023724426818270771146546847147459019021727433413814114715215816416816915714114112511711811811701940
> Total Liabilities 
0
10,646
0
11,847
12,243
916
1,040
919
690
1,162
1,056
911
939
1,336
1,739
1,966
1,958
1,530
1,433
1,334
1,526
1,811
1,643
1,730
1,884
1,790
1,787
1,387
1,448
1,586
1,694
2,578
2,566
3,295
8,404
9,065
2,860
5,836
10,999
5,349
9,089
7,794
8,679
27,159
36,278
35,285
32,477
27,134
27,073
28,474
30,615
31,288
15,947
16,386
16,386
12,352
12,813
16,259
17,501
18,508
16,259
18,690
17,999
19,432
21,137
20,886
21,718
19,100
20,575
21,179
31,307
31,247
31,435
30,441
29,802
38,295
31,000
31,00038,29529,80230,44131,43531,24731,30721,17920,57519,10021,71820,88621,13719,43217,99918,69016,25918,50817,50116,25912,81312,35216,38616,38615,94731,28830,61528,47427,07327,13432,47735,28536,27827,1598,6797,7949,0895,34910,9995,8362,8609,0658,4043,2952,5662,5781,6941,5861,4481,3871,7871,7901,8841,7301,6431,8111,5261,3341,4331,5301,9581,9661,7391,3369399111,0561,1626909191,04091612,24311,847010,6460
   > Total Current Liabilities 
0
691
0
1,246
1,318
916
1,040
919
690
1,162
1,056
911
939
1,336
1,739
1,966
1,958
1,530
1,433
1,334
1,526
1,811
1,643
1,678
1,806
1,686
1,674
1,266
1,318
1,448
1,554
2,396
2,355
3,019
2,264
3,729
2,629
5,652
10,860
5,234
3,953
2,686
3,885
16,553
15,267
6,780
5,562
4,394
4,621
6,133
7,564
8,440
6,126
7,672
7,672
4,200
4,791
8,615
10,135
11,137
8,615
17,434
16,804
16,601
18,680
18,838
20,106
17,779
12,154
12,802
14,419
14,362
14,158
13,426
13,058
14,120
12,025
12,02514,12013,05813,42614,15814,36214,41912,80212,15417,77920,10618,83818,68016,60116,80417,4348,61511,13710,1358,6154,7914,2007,6727,6726,1268,4407,5646,1334,6214,3945,5626,78015,26716,5533,8852,6863,9535,23410,8605,6522,6293,7292,2643,0192,3552,3961,5541,4481,3181,2661,6741,6861,8061,6781,6431,8111,5261,3341,4331,5301,9581,9661,7391,3369399111,0561,1626909191,0409161,3181,24606910
       Short-term Debt 
0
229
0
0
0
0
0
0
0
0
0
0
0
-74,196
0
1,035
907
832
0
0
0
0
0
0
0
0
0
0
0
0
552
977
913
957
887
353
879
844
820
303
1,011
842
651
7,238
8,887
299
195
93
857
2,053
2,810
3,566
1,970
2,744
2,744
51
7,362
252
1,010
1,767
252
7,588
7,618
8,427
8,770
9,122
9,461
7,661
359
318
289
224
246
355
381
392
404
4043923813552462242893183597,6619,4619,1228,7708,4277,6187,5882521,7671,0102527,362512,7442,7441,9703,5662,8102,053857931952998,8877,2386518421,0113038208448793538879579139775520000000000008329071,0350-74,196000000000002290
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,001
0
0
0
19,989
0
0
0
1,714
2,810
25,102
1,936
2,387
3,410
7,372
0
252
1,010
1,767
2,524
7,275
7,275
8,074
8,409
8,753
9,086
7,278
0
0
0
0
0
0
0
0
0
0000000007,2789,0868,7538,4098,0747,2757,2752,5241,7671,01025207,3723,4102,3871,93625,1022,8101,71400019,9890005,00100000000000000000000000000000000000000000
       Accounts payable 
0
339
0
234
303
329
230
256
384
641
486
408
427
568
718
885
1,021
634
655
422
839
1,187
1,089
736
1,058
1,097
854
646
630
671
940
1,329
1,278
1,850
1,085
1,809
1,425
1,479
1,311
1,117
1,272
1,240
1,320
4,841
6,113
6,607
3,503
2,623
3,437
3,845
2,206
2,301
1,907
4,637
4,637
3,807
4,464
6,264
6,769
2,091
1,764
1,880
2,102
2,451
3,488
2,764
3,151
2,642
2,480
2,822
3,970
4,241
4,369
3,425
3,099
3,880
3,157
3,1573,8803,0993,4254,3694,2413,9702,8222,4802,6423,1512,7643,4882,4512,1021,8801,7642,0916,7696,2644,4643,8074,6374,6371,9072,3012,2063,8453,4372,6233,5036,6076,1134,8411,3201,2401,2721,1171,3111,4791,4251,8091,0851,8501,2781,3299406716306468541,0971,0587361,0891,1878394226556341,02188571856842740848664138425623032930323403390
       Other Current Liabilities 
0
17
0
1,012
1,015
587
810
662
306
521
570
502
512
19
1,021
22
27
27
777
912
687
624
554
942
748
590
820
620
688
777
45
43
82
41
61
1,276
58
3,085
8,527
3,663
1,585
561
1,888
4,112
1,920
-299
1,639
1,474
1,538
1,992
2,214
2,160
1,899
291
2,216
-51
-7,362
2,099
2,356
2,486
4,500
5,134
5,150
4,703
4,558
4,690
5,286
5,101
5,548
6,377
7,039
6,644
6,575
6,868
7,030
7,412
6,079
6,0797,4127,0306,8686,5756,6447,0396,3775,5485,1015,2864,6904,5584,7035,1505,1344,5002,4862,3562,099-7,362-512,2162911,8992,1602,2141,9921,5381,4741,639-2991,9204,1121,8885611,5853,6638,5273,085581,27661418243457776886208205907489425546246879127772727221,021195125025705213066628105871,0151,0120170
   > Long-term Liabilities 
0
9,955
0
10,602
10,925
10,925
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52
78
104
113
121
130
138
140
182
210
275
6,140
5,336
231
184
139
115
5,136
5,108
4,794
10,606
21,011
28,505
26,915
22,740
22,452
22,341
23,051
22,848
9,821
8,714
8,714
8,152
8,022
7,644
7,366
7,371
7,644
1,256
1,195
2,831
2,457
2,048
1,612
1,321
8,421
8,377
16,888
16,885
17,277
17,015
16,744
24,175
18,975
18,97524,17516,74417,01517,27716,88516,8888,3778,4211,3211,6122,0482,4572,8311,1951,2567,6447,3717,3667,6448,0228,1528,7148,7149,82122,84823,05122,34122,45222,74026,91528,50521,01110,6064,7945,1085,1361151391842315,3366,14027521018214013813012111310478520000000000000000010,92510,92510,60209,9550
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,286
5,009
0
0
0
0
5,032
5,001
4,707
0
11,373
20,983
21,652
22,169
21,947
21,780
21,643
21,536
8,842
7,853
6,869
7,321
7,362
7,145
6,421
5,699
4,980
0
0
1,729
1,394
1,050
717
497
0
0
0
0
0
0
0
14,987
0
014,98700000004977171,0501,3941,729004,9805,6996,4217,1457,3627,3216,8697,8538,84221,53621,64321,78021,94722,16921,65220,98311,37304,7075,0015,03200005,0095,2860000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52
78
104
112
121
130
138
140
182
210
276
853
327
230
184
139
115
104
107
87
193
9,638
7,104
5,084
332
206
202
989
833
440
861
1,103
780
660
499
466
405
327
178
207
206
259
288
282
311
694
666
9,208
9,201
9,168
0
8,738
8,801
0
08,8018,73809,1689,2019,2086666943112822882592062071783274054664996607801,1038614408339892022063325,0847,1049,63819387107104115139184230327853276210182140138130121112104785200000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121
130
138
140
182
210
275
299
275
231
184
139
115
104
107
86
0
9,535
7,161
5,236
556
484
464
656
588
567
417
454
493
392
111
69
22
0
0
88
135
207
254
258
262
0
0
0
0
0
0
0
306
0
03060000000262258254207135880022691113924934544175675886564644845565,2367,1619,535086107104115139184231275299275210182140138130121000000000000000000000000000
> Total Stockholder Equity
0
-3,550
0
-6,850
-8,601
18,249
15,664
13,040
10,854
21,314
18,672
15,718
23,834
20,772
16,603
11,757
18,615
15,089
11,222
7,629
24,602
30,316
30,872
26,477
36,974
31,799
27,028
22,781
18,848
29,807
24,431
19,323
17,574
13,975
23,432
17,534
10,290
8,296
6,355
7,142
15,224
12,276
7,543
27,253
15,876
16,087
15,032
17,272
15,877
14,719
12,592
11,614
23,917
22,245
22,245
33,300
33,377
31,248
30,238
29,459
31,248
28,653
28,048
26,778
25,927
25,892
24,136
25,799
26,183
25,414
23,780
22,340
21,800
21,831
19,321
16,909
16,193
16,19316,90919,32121,83121,80022,34023,78025,41426,18325,79924,13625,89225,92726,77828,04828,65331,24829,45930,23831,24833,37733,30022,24522,24523,91711,61412,59214,71915,87717,27215,03216,08715,87627,2537,54312,27615,2247,1426,3558,29610,29017,53423,43213,97517,57419,32324,43129,80718,84822,78127,02831,79936,97426,47730,87230,31624,6027,62911,22215,08918,61511,75716,60320,77223,83415,71818,67221,31410,85413,04015,66418,249-8,601-6,8500-3,5500
   Common Stock
0
2
0
2
3
11
11
11
11
13
13
13
15
15
15
15
18
18
18
18
21
22
23
23
25
25
25
25
25
30
30
30
31
32
43
43
43
48
52
5
5
6
8
9
10
10
11
11
11
11
2
3
3
4
4
30
30
30
31
34
30
33
34
34
34
34
34
34
34
34
35
35
35
35
35
35
35
3535353535353534343434343434343330343130303044332111111111010986555248434343323130303025252525252323222118181818151515151313131111111132020
   Retained Earnings Total Equity0-233,2110000000-220,309-221,391-218,973-218,530-217,276-215,596-214,561-214,046-213,186-212,104-210,771-233,508-233,218-231,863-229,406-227,686-214,015-212,810-210,575-209,688-208,179-208,677-207,240-206,647-197,413-189,566-182,293-177,789-175,501-176,128-168,148-163,538-156,133-148,711-142,200-136,121-130,765-125,280-119,527-115,005-108,894000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-228
0
-143
-135
-63
-208
-252
0
-197
-197
-197
-7
-12
-16
-3
-2
-7
-5
0
0
-944
-944
0
0
-1,461
-1,461
0
0
-2,012
-2,012
0
0
-2,969
-2,969
0
0
-5,403
-6,099
-5,307
-5,277
-5,192
-5,293
11
10
1
1
3
2
2
2
2
2
-10,734
-10,734
-233,000
-13,000
-13,532
-14,151
-14,749
-13,532
-15,962
-16,538
-16,960
-17,404
0
0
0
0
0
0
0
0
0
0
0
0
000000000000-17,404-16,960-16,538-15,962-13,532-14,749-14,151-13,532-13,000-233,000-10,734-10,734222223111011-5,293-5,192-5,277-5,307-6,099-5,40300-2,969-2,96900-2,012-2,01200-1,461-1,46100-944-94400-5-7-2-3-16-12-7-197-197-1970-252-208-63-135-1430-2280
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,651
133,828
149,304
149,681
150,057
153,664
156,143
172,100
173,624
173,784
176,396
182,430
182,637
193,007
194,562
197,100
224,645
222,502
223,315
223,696
225,436
225,551
225,280
225,397
225,624
251,594
251,643
251,662
266,487
266,854
241,988
242,310
242,611
242,868
243,180
243,610
244,020
244,423
244,831
245,493
246,074
0
0
0
0
0
0
0
250,085
0
0250,0850000000246,074245,493244,831244,423244,020243,610243,180242,868242,611242,310241,988266,854266,487251,662251,643251,594225,624225,397225,280225,551225,436223,696223,315222,502224,645197,100194,562193,007182,637182,430176,396173,784173,624172,100156,143153,664150,057149,681149,304133,828131,651000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
9,611
0
9,035
8,718
39,069
39,372
39,676
39,915
52,722
53,074
53,216
64,039
64,115
64,224
64,328
75,384
76,678
75,961
76,203
98,221
110,458
115,120
115,317
130,767
132,377
131,087
131,651
133,828
151,316
149,681
150,057
153,664
159,112
172,100
173,624
173,784
181,799
188,529
187,944
198,284
199,754
202,393
224,645
222,502
223,315
223,696
225,436
225,551
225,280
225,397
234,561
251,594
0
262,377
499,487
279,854
0
0
0
255,520
259,142
260,148
260,980
261,827
244,831
245,493
246,074
246,979
247,059
247,926
248,378
248,833
249,024
249,349
250,085
250,422
250,422250,085249,349249,024248,833248,378247,926247,059246,979246,074245,493244,831261,827260,980260,148259,142255,520000279,854499,487262,3770251,594234,561225,397225,280225,551225,436223,696223,315222,502224,645202,393199,754198,284187,944188,529181,799173,784173,624172,100159,112153,664150,057149,681151,316133,828131,651131,087132,377130,767115,317115,120110,45898,22176,20375,96176,67875,38464,32864,22464,11564,03953,21653,07452,72239,91539,67639,37239,0698,7189,03509,6110



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue35,271
Cost of Revenue-14,763
Gross Profit20,50820,508
 
Operating Income (+$)
Gross Profit20,508
Operating Expense-40,300
Operating Income-5,029-19,792
 
Operating Expense (+$)
Research Development1,378
Selling General Administrative24,159
Selling And Marketing Expenses-
Operating Expense40,30025,537
 
Net Interest Income (+$)
Interest Income192
Interest Expense-1,387
Other Finance Cost-0
Net Interest Income-1,195
 
Pretax Income (+$)
Operating Income-5,029
Net Interest Income-1,195
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-7,133-5,029
EBIT - interestExpense = -1,387
-7,196
-5,809
Interest Expense1,387
Earnings Before Interest and Taxes (EBIT)--5,746
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-7,133
Tax Provision--
Net Income From Continuing Ops-7,196-7,133
Net Income-7,196
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,195
 

Technical Analysis of STRATA Skin Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of STRATA Skin Sciences Inc. The general trend of STRATA Skin Sciences Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine STRATA Skin Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of STRATA Skin Sciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.5879 < 0.589 < 0.6.

The bearish price targets are: 0.44 > 0.4009 > 0.262.

Tweet this
STRATA Skin Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of STRATA Skin Sciences Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

STRATA Skin Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of STRATA Skin Sciences Inc. The current macd is -0.01456301.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the STRATA Skin Sciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for STRATA Skin Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the STRATA Skin Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
STRATA Skin Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartSTRATA Skin Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of STRATA Skin Sciences Inc. The current adx is 16.11.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy STRATA Skin Sciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
STRATA Skin Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of STRATA Skin Sciences Inc. The current sar is 0.54679049.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
STRATA Skin Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of STRATA Skin Sciences Inc. The current rsi is 33.51. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
STRATA Skin Sciences Inc Daily Relative Strength Index (RSI) ChartSTRATA Skin Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of STRATA Skin Sciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the STRATA Skin Sciences Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
STRATA Skin Sciences Inc Daily Stochastic Oscillator ChartSTRATA Skin Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of STRATA Skin Sciences Inc. The current cci is -177.40695126.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
STRATA Skin Sciences Inc Daily Commodity Channel Index (CCI) ChartSTRATA Skin Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of STRATA Skin Sciences Inc. The current cmo is -44.3732982.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
STRATA Skin Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartSTRATA Skin Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of STRATA Skin Sciences Inc. The current willr is -96.9375.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
STRATA Skin Sciences Inc Daily Williams %R ChartSTRATA Skin Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of STRATA Skin Sciences Inc.

STRATA Skin Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of STRATA Skin Sciences Inc. The current atr is 0.04269588.

STRATA Skin Sciences Inc Daily Average True Range (ATR) ChartSTRATA Skin Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of STRATA Skin Sciences Inc. The current obv is 10,431,410.

STRATA Skin Sciences Inc Daily On-Balance Volume (OBV) ChartSTRATA Skin Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of STRATA Skin Sciences Inc. The current mfi is 14.21.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
STRATA Skin Sciences Inc Daily Money Flow Index (MFI) ChartSTRATA Skin Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for STRATA Skin Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

STRATA Skin Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of STRATA Skin Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.507
Ma 20Greater thanMa 500.502
Ma 50Greater thanMa 1000.515
Ma 100Greater thanMa 2000.513
OpenGreater thanClose0.470
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of STRATA Skin Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on STRATA Skin Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about STRATA Skin Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about STRATA Skin Sciences Inc

I send you an email if I find something interesting about STRATA Skin Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about STRATA Skin Sciences Inc.

Receive notifications about STRATA Skin Sciences Inc in your mailbox!